Demerit Goods

Demerit goods are a concept developed by economist Richard Musgrave to describe products whose private consumption is judged to be socially undesirable, either because consumers underestimate the harm to themselves or because consumption imposes costs on third parties. Classic examples include tobacco, alcohol, gambling, sugary drinks, and recreational drugs.

The category overlaps with, but is distinct from, goods that generate negative externalities. Externalities concern spillover costs onto others (e.g., second-hand smoke, drunk-driving accidents, public health system burdens). Demerit-good reasoning goes further: it assumes consumers themselves are not fully rational or fully informed about long-term harms, a stance sometimes called paternalistic. This makes the concept politically contested, since it justifies government intervention in private choices.

Policy instruments used to reduce consumption of demerit goods include:

• Pigouvian or excise taxes (tobacco duties, alcohol excise, the UK Soft Drinks Industry Levy introduced in 2018).
• Minimum unit pricing, such as Scotland's 50p-per-unit alcohol minimum price in force from 2018.
• Advertising restrictions and plain packaging, e.g., Australia's tobacco plain-packaging law of 2012.
• Age limits, licensing, and outright prohibition for certain substances.
• Information campaigns and health warnings mandated under instruments like the WHO Framework Convention on Tobacco Control, adopted in 2003.

In international policy debates, demerit-good arguments appear in WHO discussions on non-communicable diseases, in WTO disputes where health measures are challenged as trade barriers (notably Australia – Plain Packaging, DS435 and related cases), and in UN Sustainable Development Goal 3 targets on tobacco and harmful alcohol use.

Critics argue the concept can mask moral judgments as economics, may be regressive (excise taxes fall harder on lower-income households), and can fuel illicit markets when taxes or bans are aggressive. Supporters counter that market prices systematically fail to capture future health costs, addiction dynamics, and external harms, making some corrective intervention efficient as well as paternalistic.